Sheila Mikhail

Sheila Mikhail

Company: AskBio

Job title: Co-Founder & Former Chief Executive Officer

Bio:

Sheila has started and successfully exited several gene therapy companies, including Chatham Therapeutics (sold to Baxter 2014), Bamboo Therapeutics (sold to Pfizer 2016), and AskBio (sold to Bayer 2020). She deployed several creative funding strategies and only raised institutional capital once in 2019.

Seminars:

Making the Case for Gene Therapy in a Tough Market 3:15 pm

Alternative funding strategies for a tough financing market Unusual business models for ultra-rare indications and emerging economies Making the commercial proposition for gene therapies more valuableRead more

day: Day One PM

Maintaining investment incentives for rare disease programs 9:00 am

Topics to be Discussed: How to attract investment into a rare gene therapy program Demonstrating value proposition to potential investors Considerations for diseases with other treatment options Outlining required capabilities and infrastructure for scaling up a biotechRead more

day: decision makers day - track a

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.